Learn / CJC-1295 (no DAC)

GH axis

CJC-1295 (no DAC)

Also known as Modified GRF (1-29)

CJC-1295 without DAC, also called Modified GRF (1-29), is an analogue of growth-hormone-releasing hormone (GHRH). It is based on the first 29 amino acids of GHRH, the shortest fragment with full activity, with four amino-acid substitutions that make it more resistant to breakdown.

"DAC" (drug affinity complex) is a chemical group added to a different version, CJC-1295 with DAC, so that it binds albumin and lasts much longer. This product has no DAC.

Structure and form

Molecular formula	C152H252N44O42
Molecular weight	3367.9 g/mol
Form	Lyophilised powder
Storage	−20 °C, protect from light

Research background

GHRH analogues are used in research on the growth-hormone axis and GHRH receptor signalling.

CJC-1295 is not an approved medicine. GHRH and its analogues are on the World Anti-Doping Agency's prohibited list.

Storage and handling

Supplied as a lyophilised (freeze-dried) powder in a sealed 4 ml vial. Keep it sealed until use. Storage: −20 °C, protect from light. Once reconstituted, solutions are usually kept refrigerated at 2–8 °C and used promptly. Follow your laboratory's own protocols and safety data.

Is CJC-1295 (no DAC) approved for human use?

No. CJC-1295 (no DAC) is sold by vialinepeptides strictly for in-vitro laboratory research. It is not a medicine, food or cosmetic and is not for human or veterinary use. Nothing on this page is medical advice.

All products are sold strictly for in-vitro laboratory research. They are not medicines, food or cosmetics, and are not for human or veterinary use. Buyers must be 18 or over.